Skip to content
Clinical Trials – home
Research site

Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco Di Catania

Italy Viale Azeglio Ciampi Snc, 95121 Catania, Italy

  • 2 trials recruiting
  • Pancreatic failure · Systemic scleroderma · Interstitial lung disease
  • Adult patients

About Specializations

Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco Di Catania in Catania, Italy specialises in clinical trials of conditions such as Pancreatic failure, Systemic scleroderma, Interstitial lung disease, and other specialisations. This site conducts important research.

Main research areas of the site

Skin and Connective Tissue Diseases

The department focuses on systemic sclerosis-associated interstitial lung disease, aiming to assess new treatments that may slow lung function decline and improve quality of life.

  • Evaluation of belimumab as an adjunct therapy
  • Measurement of forced vital capacity changes
  • Comparison with standard care

Research at the Azienda Ospedaliero Universitaria Policlinico G Rodolico San Marco Di Catania supports advances in managing this rare connective‑tissue disorder.

Nutritional and Metabolic Diseases

Studies target exocrine pancreatic insufficiency, investigating the safety of novel lipase formulations to enhance digestive enzyme replacement.

  • Safety profiling of NHS7108
  • Assessment of nutrient absorption efficiency
  • Comparison with existing pancrelipase therapy

The site’s work contributes to better nutritional support for patients with pancreatic enzyme deficits.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Viale Azeglio Ciampi Snc95121 CataniaItaly
Recruiting now
2 trials
Conditions studied
3

More sites in CataniaItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Belimumab
  • Sponsor:Glaxosmithkline Research & Development Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.